Back to search
Prenatal Exposure
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prenatal Exposure trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prenatal Exposure trials you may qualify forIn-utero exposure to drugs and chemicals through maternal smoking, alcohol use, drug abuse, prescription medicines and occupational/lifestyle exposures is wides…
The purpose of the study is to evaluate fetal, maternal, and infant outcomes through 12 months of age.
This is a Phase 4 observational study designed to assess the impact of Palynziq ® (pegvaliase) treatment in pregnant women with PKU and on their offspring who w…
The purpose of this registry study is to collect both prospective and retrospective data in women exposed to palopegteriparatide during pregnancy to assess risk…
Introduction: Endometriosis is a common pathology affecting one in 10 women, characterized by the ectopic development of endometrium, which can cause pain and/…
This is a multi-country, prospective safety study of pregnant women exposed to efgartigimod or efgartigimod PH20 SC any time within 25 days prior to conception…
Prenatal exposure to tobacco smoke, whether from active maternal smoking or secondhand exposure, has been associated with adverse neonatal adaptation, metabolic…
The purpose of this study is to identify the best combination of new intervention components to use with CARRII, the first automated online intervention for alc…
Folic acid is currently considered to be the standard of care for primary and secondary prevention of spina bifida, but the mechanisms underlying folic acid's b…